BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16217683)

  • 1. Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker.
    Bragantini E; Barbi S; Beghelli S; Moore PS; de Manzoni G; Roviello F; Tomezzoli A; Vindigni C; Baffa R; Scarpa A
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):45-50. PubMed ID: 16217683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.
    Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP
    J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
    Xiao YP; Wu DY; Xu L; Xin Y
    World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.
    Ginestier C; Bardou VJ; Popovici C; Charafe-Jauffret E; Bertucci F; Geneix J; Adélaïde J; Chaffanet M; Hassoun J; Viens P; Jacquemier J; Birnbaum D
    Int J Cancer; 2003 Dec; 107(5):854-62. PubMed ID: 14566838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients.
    Zhao P; Liu W; Lu YL
    World J Gastroenterol; 2005 Sep; 11(36):5735-8. PubMed ID: 16237777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.
    Mori M; Mimori K; Masuda T; Yoshinaga K; Yamashita K; Matsuyama A; Inoue H
    Cancer Res; 2001 Oct; 61(20):7379-82. PubMed ID: 11606365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
    Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
    World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
    Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
    Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status.
    Bria E; De Manzoni G; Beghelli S; Tomezzoli A; Barbi S; Di Gregorio C; Scardoni M; Amato E; Frizziero M; Sperduti I; Corbo V; Brunelli M; Bersani S; Tortora G; Scarpa A
    Ann Oncol; 2013 Mar; 24(3):693-701. PubMed ID: 23131390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer.
    Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Bader G; Iusco D; Salvemini C; Caruso G; Donadei E; Pizzi S; D'Adda T; Renato C; Roncoroni L; Bordi C
    Eur J Cancer; 2004 Jul; 40(10):1581-8. PubMed ID: 15196543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.